Total Health
Total Health is the largest provider of free cancer care resources for people who are treating or living with cancer. Our programs arm cancer care teams with the latest research and strategies to improve patient outcomes.
For more info visit our website at Total Health.
Videos
Total Health
Does Neratinib Affect IDFS After Adjuvant Trastuzumab? Final Efficacy Results of ExteNET Trial
- 62 views
- January 12, 2021
Total Health
Adjuvant Pertuzumab & T-DM1 for HER2+ EBC: How Effective Are They?
- 15 views
- January 12, 2021
Total Health
2020 Update on Molecular Subtyping in BC: Can MammaPrint, BluePrint, and Rapid Genomic Testing Improve Neoadjuvant Decision-Making?
FEATURING
Lee Schwartzberg
- 268 views
- November 4, 2020
- 4
Total Health
2020 ASCO Update on EBC De-Escalation: Can the Use of MammaPrint Spare Patients from Unnecessary Chemotherapy?
FEATURING
Martin Dietrich
- 20 views
- November 4, 2020
Total Health
2020 ASCO MINDACT Trial Data on MammaPrint in EBC: Can Genomic Profiling Help Prevent Chemotherapy?
FEATURING
Ranju Gupta
- 13 views
- November 4, 2020
Total Health
HER2+ MBC in 2020: How Should You Properly Sequence Recently Approved Neratinib, Pertuzumab & T-DM1?
- 325 views
- October 13, 2020
- 3
Total Health
2020 Update on Early Stage BC: Is the Benefit Observed in 50+ y/o Women Due to Chemo Effect or Ovarian Suppression?
FEATURING
Reshma L. Mahtani
- 282 views
- September 28, 2020
Total Health
2020 Update on De-Escalation in Early Stage BC: Can MammaPrint Help Identify Patients Who May Safely Avoid Chemotherapy?
FEATURING
Hope Rugo,
Reshma L. Mahtani
- 140 views
- September 28, 2020
Total Health
60 y/o Female with HR+/HER2- Early Stage BC: Will Genomic Information Be Helpful in the Management of This Patient?
FEATURING
Hope Rugo,
Reshma L. Mahtani
- 493 views
- September 28, 2020
- 1
Total Health
45 y/o Female With HR+/HER2- What Is Best Early Stage Option for This Patient?
FEATURING
Hope Rugo,
Reshma L. Mahtani
- 330 views
- September 28, 2020
- 1